It was found that bradykinin induces tumor-associated angiogenesis by promoting the release of vascular endothelial growth factor (VEGF), facilitated cancer invasion, and metastases by activating matrix metalloproteinase (28, 29). This evidence concerns the gene VEGFA and neoplasm.